Comparison of commercial iron oxide-based MRI contrast agents with synthesized high-performance MPI tracers

Biomedizinische Technik

Volumn 58, Issue 6, 2013, Pages 527-533

  Lüdtke Buzug, Kerstin ^a   Haegele, Julian ^b   Biederer, Sven ^a   Sattel, Timo F ^a   Erbe, Marlitt ^a   Duschka, Robert L ^b   Barkhausen, Jörg ^b   Vogt, Florian M ^b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

iron oxide; magnetic particle imaging; magnetic particle spectroscopy; nanoparticles; SPIO

Indexed keywords

HIGH SPATIAL RESOLUTION; MAGNETIC PARTICLE; MAGNETIC PARTICLE IMAGING; PARTICLE PERFORMANCE; SPIO; SUPERPARAMAGNETIC IRON OXIDES; SUPERPARAMAGNETIC PARTICLES; SYNTHESIS TECHNIQUES;

HARMONIC ANALYSIS; IRON; IRON OXIDES; MAGNETIC BUBBLES; NANOMAGNETICS; NANOPARTICLES; PARTICLE SPECTROMETERS; SUPERPARAMAGNETISM;

SYNTHESIS (CHEMICAL);

CONTRAST MEDIUM; DEXTRAN; DIAGNOSTIC AGENT; FERUMOXTRAN-10; MAGNETITE NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; COMPARATIVE STUDY; EQUIPMENT; HUMAN; IMAGE ENHANCEMENT; IMAGE QUALITY; METHODOLOGY; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

CONTRAST MEDIA; DEXTRANS; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MOLECULAR IMAGING; PHANTOMS, IMAGING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84890452075     PISSN: 00135585     EISSN: None     Source Type: Journal    
DOI: 10.1515/bmt-2012-0059     Document Type: Article

References (31)

1. Bellin MF, Roy C, Kinkel K, et al. Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles - initial clinical experience. Radiology 1998; 207: 799-808.
2. Biederer S, Knopp T, Sattel TF, et al. Magnetization response spectroscopy of superparamagnetic nanoparticles for magnetic particle imaging. J Phys D Appl Phys 2009; 42: 205007.
3. Chikazumi S, Charap S. Physics of magnetism. New York: Wiley 1964.
4. Eberbeck D, Wiekhorst F, Wagner S, et al. How the size distribution of magnetic nanoparticles determines their magnetic particle imaging performance. Appl Phys Lett 2011; 98: 182502. http://dx.doi.org/10.1063/1.3586776.
5. Erbe M, Sattel TF, Buzug TM. Improved magnetic particle spectrometer providing high field amplitudes for investigation of hysteresis effect in superparamagnetic nanoparticle tracers. World molecular imaging congress, Dublin, 2012.
6. Ferguson RM, Minard KR, Khandhar AP, et al. Optimizing magnetite nanoparticles for mass sensitivity in magnetic particle imaging. Med Phys 2011; 38: 1619-1626.
7. Fleige G, Nolte C, Synowitz M, et al. Magnetic labeling of activated microglia in experimental gliomas. Neoplasia 2001; 3: 489-499.
8. Gleich B, Weizenecker J. Tomographic imaging using the nonlinear response of magnetic particles. Nature 2005; 435: 1214-1217.
9. Gleich B, Weizenecker J, Borgert J. Experimental results on fast 2D-encoded magnetic particle imaging. Phys Med Biol 2008; 53: N81-84.
10. Goodwill PW, Tamrazian A, Croft LR, et al. Ferrohydrodynamic relaxometry for magnetic particle imaging. App Phys Lett 2011; 98: 262502. http://dx.doi.org/10.1063/1.3604009.
11. Grüttner M, Gräser M, Biederer S, et al. 1D-image reconstruction for magnetic particle imaging using a hybrid system function. Proc IEEE Nuc Sci Symp Med Im Conf 2011: 2545-2548.
12. Kalapis U, Lüdtke-Buzug K. Magnetic methods for separation and purification of superparamagnetic iron oxide nanoparticles. Biomed Tech 2011; 56(Suppl. 1). DOI 10.1515/BMT.2011.630.
13. Knopp T, Biederer S, Sattel T, et al. Trajectory analysis for magnetic particle imaging. Phys Med Biol 2009; 54: 385-397.
14. Knopp T, Biederer S, Sattel TF, et al. 2D Model-based reconstruction for magnetic particle imaging. Med Phys 2010; 37: 485-491.
15. Knopp T, Sattel T, Biederer S, et al. Model-based reconstruction for magnetic particle imaging. IEEE Trans Med Imag 2010; 29: 12-18.
16. Krishnan KM. Biomedical nanomagnetics: a spin through possibilities in imaging, diagnostics, and therapy. IEEE Trans Magn 2010; 46: 2523-2558.
17. Lüdtke-Buzug K. Von der synthese zur klinischen anwendung: magnetische nanopartikel. Chem Unserer Zeit 2012; 46: 32-39.
18. Lüdtke-Buzug K, Biedere S, Sattel T, et al. Particle-size distribution of dextran- and carboxydextran-coated superparamagnetic nanoparticles for magnetic particle imaging. In: Doessel O, Schlegel WC, editors. World congress on medical physics and biomedical engineering, Springer IFMBE Series. Munich: Springer 2009: 226-229.
19. Rahmer J, Weizenecker J, Gleich B, et al. Signal encoding in magnetic particle imaging: properties of the system function. BMC Med Imaging 2009; 9: 4. DOI:10.1186/1471-2342-9-4.
20. Rauwerdink AM, Weaver JB. Concurrent quantification of multiple nanoparticle bound states. Med Phys 2011; 38: 1136-1140.
21. Ruehm SG, Corot C, Vogt P, et al. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 2001; 103: 415-422.
22. Sattel T, Knopp T, Biederer S, et al. Single-sided device for magnetic particle imaging. J Phys D Appl Phys 2009; 42: 1-5.
23. Schmale I, Rahmer J, Gleich B, Borgert J, Weizenecker J. Point spread function analysis of magnetic particle imaging. SPPHY 140, 2012: 287-292.
24. Seneterre E, Weissleder R, Jaramillo D, et al. Bone marrow: ultrasmall superparamagnetic iron oxide for MR imaging. Radiology 1991; 179: 529-533.
25. Snyder S, Heinen U. Characterization of magnetic nanoparticles for therapy and diagnostics. Ettlingen, Germany: Bruker BioSpin 2010.
26. Sun C, Lee JS, Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev 2008; 60: 1252-1265.
27. Weaver JB, Rauwerdink AM, Sullivan CR, et al. Frequency distribution of the nanoparticle magnetization in the presence of a static as well as a harmonic magnetic field. Med Phys 2008; 35: 1988-1994.
28. Weizenecker J, Borgert J, Gleich B. A simulation study on the resolution and sensitivity of magnetic particle imaging. Phys Med Biol 2007; 52: 6363-6374.
29. Weizenecker J, Gleich B, Rahmer J, et al. Three-dimensional real-time in vivo magnetic particle imaging. Phys Med Biol 2009; 54: L1-L10.
30. Weissleder R, Hahn PF, Stark DD, et al. Superparamagnetic iron oxide: enhanced detection of focal splenic tumors with MR imaging. Radiology 1988; 169: 399-403.
31. Weissleder R, Stark DD, Engelstad BL, et al. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol 1989; 152: 167-173.